Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

FTSE 100 News

FTSE 100

FTSE 100 (UKX) Index Information
Index Value: 10,507.06
Change:  -0.96 (-0.01%)
Open: 10,507.83
High: 10,521.03
Low: 10,473.07
Yest. Close: 10,508.01953
FTSE 100 Live PriceLast checked at -
UK gilt selloff triggers limited pension cash calls, advisers say
27 Mar 2026

UK gilt selloff triggers limited pension cash calls, advisers say

* Middle East conflict causes UK bond sell-off, affecting pension funds

Market News Xps Pensions + 2 more shares
DIRECTOR DEALINGS: Arbuthnot, Everyman and S4 directors buy shares
27 Mar 2026

DIRECTOR DEALINGS: Arbuthnot, Everyman and S4 directors buy shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately...

IN BRIEF: Experian non-executive buys USD60,000 in shares
27 Mar 2026

IN BRIEF: Experian non-executive buys USD60,000 in shares

Experian PLC - Dublin-based consumer credit checker - Non-Executive Director Kathleen DeRose buys 1,750 shares at USD33.74 each, for USD59,050 in tota...

LONDON MARKET MIDDAY: Shares slide as Iran tensions deepen
27 Mar 2026

LONDON MARKET MIDDAY: Shares slide as Iran tensions deepen

(Alliance News) - Stock prices in London were lower at midday Friday, with losses accelerating after a muted open as conflicting signals over Iran wei...

Market News Harbour Energy + 5 more shares
Dubai crude's premium slumps as sellers pile offers on to TotalEnergies
27 Mar 2026

Dubai crude's premium slumps as sellers pile offers on to TotalEnergies

* Dubai's premium slumps to 65% on week

Commodities Total Energies + 2 more shares
Norway adds $12 billion to its long-term defence plan
27 Mar 2026

Norway adds $12 billion to its long-term defence plan

OSLO, ​March ⁠27 (Reuters) - Norway ​will ​increase ‌the spending ⁠in its ⁠long-term ​defence plan by ​115 ‌billion ​Norwegian crowns ($11.87 ‌billion...

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay
27 Mar 2026

WINNERS & LOSERS: Metlen Energy takes hit from annual results delay

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Risers and Fallers Natwest + 21 more shares
LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills
27 Mar 2026

LONDON BROKER RATINGS: BofA raises Berkeley; UBS raises Savills

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday day:

Nearly half a million Lloyds customers hit by data breach after glitch
27 Mar 2026

Nearly half a million Lloyds customers hit by data breach after glitch

(Alliance News) - Lloyds Banking Group PLC has paid out compensation after nearly half a million people were impacted by an IT glitch exposing the per...

LONDON MARKET OPEN: Stocks mixed as Brent oil nears USD110
27 Mar 2026

LONDON MARKET OPEN: Stocks mixed as Brent oil nears USD110

(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 edging higher despite continued uncertainty regarding Iran peace ta...

Market News Metlen Energy + 3 more shares
European Medicine Agency to review GSK's chronic hepatitis B treatment
27 Mar 2026

European Medicine Agency to review GSK's chronic hepatitis B treatment

(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepi...

Angola's Etu Energias to buy stakes in offshore projects of BP-Eni venture
27 Mar 2026

Angola's Etu Energias to buy stakes in offshore projects of BP-Eni venture

CAPE TOWN, March ​27 (Reuters) - Angola's ⁠Etu Energias has signed ​a deal with BP and Eni's ​Azule ‌Energy to buy stakes in two offshore ⁠projects, t...

Oil & Gas BP + 1 more share
AstraZeneca hails positive results in tozorakimab lung disease trials
27 Mar 2026

AstraZeneca hails positive results in tozorakimab lung disease trials

(Alliance News) - AstraZeneca PLC on Friday reported positive phase-three trial results for its chronic obstructive pulmonary disease treatment tozora...

GSK submits bepirovirsen for EMA review after trials hit primary endpoints
27 Mar 2026

GSK submits bepirovirsen for EMA review after trials hit primary endpoints

(Sharecast News) - Drugmaker GSK said on Friday that the European Medicines Agency will review its marketing authorisation application for the use of ...

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review
27 Mar 2026

LONDON BRIEFING: UK retail sales fall; GSK drug accepted for review

(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regu...